Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Raising the bar for cancer therapy models.

Literature DB >> 20531333

Raising the bar for cancer therapy models.

Giulio Francia, Robert S Kerbel.

Abstract

Entities: Disease

Mesh：

Year: 2010 PMID： 20531333 DOI： 10.1038/nbt0610-561

Source DB: PubMed Journal: Nat Biotechnol ISSN： 1087-0156 Impact factor: 54.908

× No keyword cloud information.

11 in total

Review 1. Can the pharmaceutical industry reduce attrition rates?

Authors: Ismail Kola; John Landis
Journal: Nat Rev Drug Discov Date: 2004-08 Impact factor: 84.694

2. Evaluation of antitumor activity in a human breast tumor/nude mouse model with a special emphasis on treatment dose.

Authors: M Inaba; T Kobayashi; T Tashiro; Y Sakurai; K Maruo; Y Ohnishi; Y Ueyama; T Nomura
Journal: Cancer Date: 1989-10-15 Impact factor: 6.860

Review 3. Murine models to evaluate novel and conventional therapeutic strategies for cancer.

Authors: James E Talmadge; Rakesh K Singh; Isaiah J Fidler; Avraham Raz
Journal: Am J Pathol Date: 2007-03 Impact factor: 4.307

4. Assessing therapeutic responses in Kras mutant cancers using genetically engineered mouse models.

Authors: Mallika Singh; Anthony Lima; Rafael Molina; Patricia Hamilton; Anne C Clermont; Vidusha Devasthali; Jennifer D Thompson; Jason H Cheng; Hani Bou Reslan; Calvin C K Ho; Timothy C Cao; Chingwei V Lee; Michelle A Nannini; Germaine Fuh; Richard A D Carano; Hartmut Koeppen; Ron X Yu; William F Forrest; Gregory D Plowman; Leisa Johnson
Journal: Nat Biotechnol Date: 2010-05-23 Impact factor: 54.908

5. Highly efficacious nontoxic preclinical treatment for advanced metastatic breast cancer using combination oral UFT-cyclophosphamide metronomic chemotherapy.

Authors: Raquel Munoz; Shan Man; Yuval Shaked; Christina R Lee; John Wong; Giulio Francia; Robert S Kerbel
Journal: Cancer Res Date: 2006-04-01 Impact factor: 12.701

Review 6. Recent developments of targeted therapies in the treatment of non-small cell lung cancer.

Authors: Antonio Rossi; Paolo Maione; Giuseppe Colantuoni; Carmine Ferrara; Emanuela Rossi; Ciro Guerriero; Dario Nicolella; Marzia Falanga; Giovanni Palazzolo; Cesare Gridelli
Journal: Curr Drug Discov Technol Date: 2009-06

7. Comparative impact of trastuzumab and cyclophosphamide on HER-2-positive human breast cancer xenografts.

Authors: Giulio Francia; Shan Man; Chyan-Jang Lee; Christina R Lee; Ping Xu; Miriam E Mossoba; Urban Emmenegger; Jeffrey A Medin; Robert S Kerbel
Journal: Clin Cancer Res Date: 2009-10-13 Impact factor: 12.531

Review 8. Integrating pharmacology and in vivo cancer models in preclinical and clinical drug development.

Authors: J K Peterson; P J Houghton
Journal: Eur J Cancer Date: 2004-04 Impact factor: 9.162

Review 9. Maximizing mouse cancer models.

Authors: Kristopher K Frese; David A Tuveson
Journal: Nat Rev Cancer Date: 2007-09 Impact factor: 60.716

10. Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis.

Authors: John M L Ebos; Christina R Lee; William Cruz-Munoz; Georg A Bjarnason; James G Christensen; Robert S Kerbel
Journal: Cancer Cell Date: 2009-03-03 Impact factor: 31.743

19 in total

1. Intratumoral mediated immunosuppression is prognostic in genetically engineered murine models of glioma and correlates to immunotherapeutic responses.

Authors: Ling-Yuan Kong; Adam S Wu; Tiffany Doucette; Jun Wei; Waldemar Priebe; Gregory N Fuller; Wei Qiao; Raymond Sawaya; Ganesh Rao; Amy B Heimberger
Journal: Clin Cancer Res Date: 2010-10-04 Impact factor: 12.531

2. Drug development: Raise standards for preclinical cancer research.

Authors: C Glenn Begley; Lee M Ellis
Journal: Nature Date: 2012-03-28 Impact factor: 49.962

Review 3. Antiangiogenic therapy: impact on invasion, disease progression, and metastasis.

Authors: John M L Ebos; Robert S Kerbel
Journal: Nat Rev Clin Oncol Date: 2011-03-01 Impact factor: 66.675

Review 4. Critical evaluation of challenges and future use of animals in experimentation for biomedical research.

Authors: Vijay Pal Singh; Kunal Pratap; Juhi Sinha; Koundinya Desiraju; Devika Bahal; Ritushree Kukreti
Journal: Int J Immunopathol Pharmacol Date: 2016-09-30 Impact factor: 3.219

5. Changes in ovarian tumor cell number, tumor vasculature, and T cell function monitored in vivo using a novel xenograft model.

Authors: Sandra J Yokota; John G Facciponte; Raymond J Kelleher; Leonard D Shultz; Jenni L Loyall; Robert R Parsons; Kunle Odunsi; John G Frelinger; Edith M Lord; Scott A Gerber; Sathy V Balu-Iyer; Richard B Bankert
Journal: Cancer Immun Date: 2013-05-31